Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Managed care aspects of managing neurogenic bladder/neurogenic detrusor overactivity.
Multiple sclerosis: Could simvastatin slow down secondary progressive MS?
Are There Differences in the Prevalence of Palliative Care-Related Problems in People Living With Advanced Cancer and Eight Non-Cancer Conditions? A Systematic Review.
Th17 and Non-Classic Th1 Cells in Chronic Inflammatory Disorders: Two Sides of the Same Coin.
The multiple sclerosis self-management scale: clinicometric testing.
The central role of mitochondria in axonal degeneration in multiple sclerosis.
Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis.
Melatonin Lulling Th17 Cells to Sleep.
MRI in the Evaluation of Acute Visual Syndromes.
Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab.
Saturable Leptin Transport Across the BBB Persists in EAE Mice.
Neurological diseases in pregnancy.
Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement.
Limited utility of current MRI criteria for distinguishing multiple sclerosis from common mimickers: primary and secondary CNS vasculitis, lupus and Sjogren's syndrome.
Recognition performance differentiates between elderly patients in the long term course of secondary progressive multiple sclerosis and amnestic mild cognitive impairment.
Effect of interferon beta-1a on B7.1 and B7.2 B-cell expression and its impact on T-cell proliferation.
Sleep-disordered breathing in multiple sclerosis.
Direct and indirect affection of the central nervous system by Fasciola infection.
Etiologic exploration of magnetic resonance tomographic angiography negative trigeminal neuralgia.
High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.
Persistence and pathogenesis of the neurotropic polyomavirus JC.
Clinically Significant Fatigue: Prevalence and Associated Factors in an International Sample of Adults with Multiple Sclerosis Recruited via the Internet.
Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients.
Oligodendrocyte Development and Myelination in Neurodevelopment: Molecular Mechanisms in Health and Disease.
pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation.
Pages
« first
‹ previous
…
411
412
413
414
415
416
417
418
419
…
next ›
last »